Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CBAT - US14986C1027 - Common Stock

0.894 USD
+0.02 (+2.75%)
Last: 11/21/2025, 8:15:41 PM
0.9 USD
+0.01 (+0.67%)
After Hours: 11/21/2025, 8:15:41 PM
Fundamental Rating

3

CBAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 90 industry peers in the Electrical Equipment industry. CBAT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CBAT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
CBAT had a positive operating cash flow in the past year.
In multiple years CBAT reported negative net income over the last 5 years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.74%, CBAT is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
CBAT's Return On Equity of -7.73% is fine compared to the rest of the industry. CBAT outperforms 62.64% of its industry peers.
Industry RankSector Rank
ROA -2.74%
ROE -7.73%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

In the last couple of years the Profit Margin of CBAT has declined.
With a Gross Margin value of 17.22%, CBAT is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CBAT has grown nicely.
The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBAT remains at a similar level compared to 1 year ago.
The number of shares outstanding for CBAT has been increased compared to 5 years ago.
CBAT has a better debt/assets ratio than last year.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CBAT has an Altman-Z score of -0.15. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
CBAT has a Altman-Z score (-0.15) which is comparable to the rest of the industry.
CBAT has a debt to FCF ratio of 14.55. This is a negative value and a sign of low solvency as CBAT would need 14.55 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.55, CBAT is in the better half of the industry, outperforming 65.93% of the companies in the same industry.
CBAT has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CBAT (0.33) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 14.56
Altman-Z -0.15
ROIC/WACCN/A
WACC5.77%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CBAT has a Current Ratio of 0.72. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
CBAT's Current ratio of 0.72 is on the low side compared to the rest of the industry. CBAT is outperformed by 83.52% of its industry peers.
CBAT has a Quick Ratio of 0.72. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CBAT (0.53) is worse than 78.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.53
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -141.18% in the last year.
Measured over the past years, CBAT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -42.83% on average per year.
CBAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.61%.
The Revenue has been growing by 51.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-13.61%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%

3.2 Future

Based on estimates for the next years, CBAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.77% on average per year.
The Revenue is expected to grow by 11.65% on average over the next years. This is quite good.
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.1 -0.1

3

4. Valuation

4.1 Price/Earnings Ratio

CBAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 10.96, the valuation of CBAT can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CBAT is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.42, CBAT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.96
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CBAT is valued a bit cheaper than the industry average as 78.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.51
EV/EBITDA -19.13
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

CBAT's earnings are expected to decrease with -20.77% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (11/21/2025, 8:15:41 PM)

After market: 0.9 +0.01 (+0.67%)

0.894

+0.02 (+2.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-16 2026-03-16/bmo
Inst Owners2.19%
Inst Owner Change25.15%
Ins Owners25.81%
Ins Owner Change0%
Market Cap79.25M
Revenue(TTM)176.61M
Net Income(TTM)-9.14M
Analysts0
Price Target1.53 (71.14%)
Short Float %0.25%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.97%
Min Revenue beat(2)-34.33%
Max Revenue beat(2)18.4%
Revenue beat(4)1
Avg Revenue beat(4)-22.71%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)18.4%
Revenue beat(8)2
Avg Revenue beat(8)-15.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.96
P/S 0.54
P/FCF 29.51
P/OCF 2.34
P/B 0.67
P/tB 0.67
EV/EBITDA -19.13
EPS(TTM)-0.07
EYN/A
EPS(NY)0.08
Fwd EY9.13%
FCF(TTM)0.03
FCFY3.39%
OCF(TTM)0.38
OCFY42.71%
SpS1.64
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.74%
ROE -7.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.22%
FCFM 1.85%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 14.56
Debt/EBITDA 449.35
Cap/Depr 393.66%
Cap/Sales 21.43%
Interest Coverage N/A
Cash Conversion 38910.2%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.53
Altman-Z -0.15
F-Score2
WACC5.77%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.61%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-127.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y121.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y148.91%
OCF growth 3YN/A
OCF growth 5YN/A

CBAK ENERGY TECHNOLOGY INC / CBAT FAQ

What is the fundamental rating for CBAT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBAT.


Can you provide the valuation status for CBAK ENERGY TECHNOLOGY INC?

ChartMill assigns a valuation rating of 3 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Overvalued.


How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.